Vascular Biogenics Ltd (VBLT)

[davidal66]

I've read the short thesis on twitter. It never made sense to me. Feurstein hates Dror, but has never described why. He stated the censoring of the patient's in the ovarian trial is a 'red flag', but that isn't true... VBLT did not 'result' the ovarian trial... it was presented by Harvard MD's at ASCO... as to the censoring... the patient's were still alive.

You can made a good short case on VBLT. The trials were small. They were not placebo controlled... also true. This is the rationale short argument and it could very well be true, but the positive results in three different cancers and phase Ia and preclinical all together builds my confidence. Is it possible that a placebo could cause a complete response/remission in rGBM by itself? VB-111 is doing that. The jury is out; i have my eyes wide open, and I think the shorts are wrong.